Venus Remedies Introduces flagship R&D Drug Elores in Oman

Venus Remedies Ltd announced later this week that its flagship R&D drug, Elores, has been launched in Oman's USD 1.4 billion pharmaceutical market. "Clinically proven to be one of the best drugs against ICU infections caused by multidrug-resistant...

NABH Introduces New Online Application Portal for its SHCO Accreditation Programme

The National Accreditation Board for Hospitals and Healthcare Providers (NABH) has launched a new online application portal for its Small Healthcare Organisations (SHCO) (maximum sanctioned bed strength of 50) Accreditation Programme....

WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat

Union Health Minister Mansukh Mandaviya today launched the first-ever WHO Traditional Medicine Global Summit at Gandhinagar's Mahatma Mandir. The meeting is being held on the sidelines of the G20 meeting of health ministers in Gandhinagar...

Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment

This ointment is the 0.03 percent generic version of Leo Pharma AS's Protopic1 ointment. Glenmark Pharmaceuticals Inc., USA will oversee the distribution of Glenmark's Tacrolimus ointment, 0.03 percent, in the United States....

TPG and Temasek contribute $80 million to Dr. Agarwal's Indian Eye Hospital Chain

Dr. Agarwal's Health Care said this week that it raised $80 million from existing investors Singapore's Temasek and U.S.-based TPG as the Indian eye hospital operator plans to double its hospital count...

Lupin Introduces Patient Support Programme, Jeet to Raise Awareness of Cardiovascular Disease among Patients

Lupin Limited (Lupin) announced the launch of Jeet, a patient support programme dedicated to heart health. The launch of the initiative coincides with India's 77th Independence Day, symbolising freedom from disease-related stress and a journey...

NPPA Modifies Guidelines for a Change in Manufacturer to Allow Existing Market Entity to Produce in its Own Plant

The National Pharmaceutical Pricing Authority (NPPA) has changed the limits in its rules for permitting manufacturers to change once the retail pricing of formulations is approved, allowing the existing marketing entity to produce the medicine...

Aurobindo Pharma Arm Eugia Pharma Receives USFDA Nod For Icatibant Injection

The US Food & Drug Administration (USFDA) has given Takeda Pharmaceuticals USA Inc's wholly owned subsidiary company, Eugia Pharma Specialities Limited, final approval to produce and market Icatibant Injection, 30 mg/3 mL (10 mg/mL), Single-Dose...

Indian Hospital Industry in the Pink of Health with Rise in NCDs & Higher Medical Tourism Volumes: ICRA Reports

The rising incidence of non-communicable lifestyle diseases, rising per capita healthcare spending, rising levels of awareness, rising health insurance penetration, and rising medical tourism volumes all contribute to ICRA's...

Rs 5,000 Crore Initiative Set to Propel India's Pharma and MedTech Sector into Rapid Growth

The scheme intends to increase the pharmaceutical industry's worth from its present level of USD 50 billion to USD 130 billion by 2030. According to reputable government sources, the health ministry will soon unveil a comprehensive five-year plan...

© 2024 India Pharma Outlook. All Rights Reserved.